How to Help Your Patients Save Money on Outgro Pain Relief: A Provider's Guide to Savings Programs

When patients ask about medication costs, providers and office staff play a critical role in directing them toward savings options. Outgro Pain Relief is an OTC product with a relatively modest price point — but with the product increasingly hard to find and only available through limited channels, patients may overpay if they don't know their options. This guide covers the complete savings landscape for Outgro Pain Relief and its clinical equivalents.

Outgro Pain Relief Cost Overview

Outgro Pain Relief retails at approximately $9.99–$15 per 0.31 fl oz (9.3 mL) bottle. This is a relatively small volume per unit, which makes the per-ounce cost higher than comparable benzocaine products sold in larger quantities. The product is typically not covered by health insurance, as it is an OTC medication.

Manufacturer Savings Programs: What to Know

There is currently no manufacturer-sponsored patient assistance program (PAP), copay savings card, or rebate program for Outgro Pain Relief. The product is made by MedTech Products Inc. and does not have a formal financial assistance pathway for patients. This is not unusual for small-volume OTC products — manufacturer assistance programs are typically reserved for higher-cost prescription medications.

FSA and HSA: The Primary Savings Vehicle for Outgro

The most impactful savings opportunity for patients using Outgro Pain Relief is Flexible Spending Account (FSA) or Health Savings Account (HSA) funds. The CARES Act (2020) expanded OTC medication eligibility for FSA and HSA purchases to include all OTC drugs without requiring a prescription. Outgro Pain Relief qualifies as an eligible OTC medication.

For patients with FSAs or HSAs, this effectively provides a 20-35% discount on Outgro (depending on their marginal tax rate), since FSA/HSA funds are pre-tax dollars. For providers, this is worth noting in patient conversations — especially for patients who are already managing FSA accounts and may not realize OTC products now qualify.

Prescription Option for Insurance Coverage (Rare but Possible)

In some clinical scenarios, a provider may write a formal prescription for benzocaine topical — effectively making it eligible for prescription drug benefits. This is clinically appropriate in specific cases (e.g., a patient with chronic ingrown toenail disease who needs ongoing topical anesthetic therapy as part of a treatment plan). Whether the patient's insurance will cover it depends on their plan's formulary.

However, given that Outgro's availability is limited and its therapeutic role is modest, prescribing a higher-concentration prescription lidocaine or a compounded topical anesthetic may be more appropriate for patients with significant ongoing needs.

The Best Cost-Saving Recommendation: Switch to Generic

The single most cost-effective recommendation for most patients using Outgro is to switch to a generic benzocaine 20% topical product. Store-brand benzocaine liquids and gels at CVS, Walmart, Walgreens, and Rite Aid:

Contain benzocaine 20% — the same active ingredient at the same concentration

Typically cost $5–$10 — often less than Outgro's branded price

Are widely available — no shortage or access issues

Qualify for FSA/HSA purchase

Comparing Cost-Effective Alternatives for Ingrown Toenail Pain

For patients whose primary concern is ingrown toenail pain, switching to Dr. Scholl's Ingrown Toenail Pain Reliever (sodium sulfide 1%) may be both clinically superior and comparably priced:

Dr. Scholl's Ingrown Toenail Pain Reliever: $8–$12 at major pharmacies; FDA-approved for this specific indication; works by softening tissue rather than just masking pain

Generic benzocaine 20%: $5–$10; same mechanism as Outgro; widely available

Outgro Pain Relief (branded): $9.99–$15; limited availability; no additional clinical benefit over generic

How medfinder Can Help Your Patients Access Medications

For patients set on finding Outgro specifically — perhaps because they've used it for years and prefer the familiar product — medication access is a real barrier in 2026. medfinder for providers is a service that calls pharmacies near the patient's location to check which ones have a medication in stock, then texts the patient the results. This can save significant time and out-of-pocket cost for patients who would otherwise drive to multiple pharmacies or overpay for online orders.

Summary: Provider Action Points

No manufacturer PAP or coupon exists for Outgro — do not send patients looking for one

FSA/HSA is the primary savings tool — remind patients that post-CARES Act, all OTC medications including Outgro are FSA/HSA-eligible without a prescription

Generic benzocaine 20% is the most cost-effective therapeutic equivalent — recommend as first choice over the branded Outgro

For ingrown toenail pain specifically, Dr. Scholl's Ingrown Toenail Pain Reliever is the FDA-approved OTC standard of care

medfinder can help patients locate any hard-to-find medication near them efficiently

For patient-facing savings information to share directly, see: How to Save Money on Outgro Pain Relief in 2026: Coupons, Discounts, and Patient Assistance